The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(1-methylpiperidin-4-yl)-2-((5-((2-oxobenzo[d]thiazol-3(2H)-yl)methyl)-4-(3-phenylpropyl)-4H-1,2,4-triazol-3-yl)thio)acetamide ID: ALA4534777
PubChem CID: 155547547
Max Phase: Preclinical
Molecular Formula: C27H32N6O2S2
Molecular Weight: 536.73
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCC(NC(=O)CSc2nnc(Cn3c(=O)sc4ccccc43)n2CCCc2ccccc2)CC1
Standard InChI: InChI=1S/C27H32N6O2S2/c1-31-16-13-21(14-17-31)28-25(34)19-36-26-30-29-24(32(26)15-7-10-20-8-3-2-4-9-20)18-33-22-11-5-6-12-23(22)37-27(33)35/h2-6,8-9,11-12,21H,7,10,13-19H2,1H3,(H,28,34)
Standard InChI Key: IKFIPSNQBKSJQX-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
13.8867 -2.1296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8856 -2.9491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5936 -3.3581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5918 -1.7208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3004 -2.1260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3053 -2.9492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0896 -3.1990 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5696 -2.5302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0818 -1.8671 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
17.3868 -2.5253 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.3467 -3.9747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1470 -4.1400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4829 -4.8818 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.2951 -4.7917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4604 -3.9913 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.7503 -3.5870 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0786 -5.5920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4915 -6.2972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0872 -7.0074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5030 -7.7072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8455 -5.3958 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
19.6438 -5.2212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1941 -5.8253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9925 -5.6508 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.9461 -6.6040 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.5428 -6.2549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1033 -8.4156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5185 -9.1149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3333 -9.1051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7312 -8.3901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3137 -7.6938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2904 -7.0307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8369 -7.6335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6365 -7.4630 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.8866 -6.6840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3372 -6.0755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1845 -8.0691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
8 10 2 0
7 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 12 2 0
13 17 1 0
17 18 1 0
18 19 1 0
20 19 1 0
14 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
23 25 2 0
24 26 1 0
20 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 20 1 0
26 32 1 0
26 36 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
34 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 536.73Molecular Weight (Monoisotopic): 536.2028AlogP: 3.64#Rotatable Bonds: 10Polar Surface Area: 85.05Molecular Species: BASEHBA: 9HBD: 1#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 8.57CX LogP: 3.18CX LogD: 1.98Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.31Np Likeness Score: -2.11
References 1. Roberti M, Schipani F, Bagnolini G, Milano D, Giacomini E, Falchi F, Balboni A, Manerba M, Farabegoli F, De Franco F, Robertson J, Minucci S, Pallavicini I, Di Stefano G, Girotto S, Pellicciari R, Cavalli A.. (2019) Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cells., 165 [PMID:30660828 ] [10.1016/j.ejmech.2019.01.008 ]